These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 30213397)

  • 1. Burkitt lymphoma- a rare but challenging lymphoma.
    Casulo C; Friedberg JW
    Best Pract Res Clin Haematol; 2018 Sep; 31(3):279-284. PubMed ID: 30213397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus and Burkitt lymphoma.
    Brady G; Macarthur GJ; Farrell PJ
    Postgrad Med J; 2008 Jul; 84(993):372-7. PubMed ID: 18716017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Epstein-Barr virus and Burkitt's lymphoma].
    Joab I
    Med Trop (Mars); 1999; 59(4 Pt 2):499-502. PubMed ID: 10901854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus and Burkitt lymphoma.
    Brady G; MacArthur GJ; Farrell PJ
    J Clin Pathol; 2007 Dec; 60(12):1397-402. PubMed ID: 18042696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosome translocation and c-MYC activation by Epstein-Barr virus and Euphorbia tirucalli in B lymphocytes.
    Aya T; Kinoshita T; Imai S; Koizumi S; Mizuno F; Osato T; Satoh C; Oikawa T; Kuzumaki N; Ohigashi H
    Lancet; 1991 May; 337(8751):1190. PubMed ID: 1673740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Burkitt lymphoma: the role of Epstein-Barr virus revisited.
    Grömminger S; Mautner J; Bornkamm GW
    Br J Haematol; 2012 Mar; 156(6):719-29. PubMed ID: 22482131
    [No Abstract]   [Full Text] [Related]  

  • 7. Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells.
    Kelly GL; Milner AE; Baldwin GS; Bell AI; Rickinson AB
    Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14935-40. PubMed ID: 17001014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus reactivation induces MYC-IGH spatial proximity and t(8;14) in B cells.
    Sall FB; Shmakova A; Karpukhina A; Tsfasman T; Lomov N; Canoy RJ; Boutboul D; Oksenhendler E; Toure AO; Lipinski M; Wiels J; Germini D; Vassetzky Y
    J Med Virol; 2023 Mar; 95(3):e28633. PubMed ID: 36866703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular resemblance of an AIDS-associated lymphoma and endemic Burkitt lymphomas: implications for their pathogenesis.
    Haluska FG; Russo G; Kant J; Andreef M; Croce CM
    Proc Natl Acad Sci U S A; 1989 Nov; 86(22):8907-11. PubMed ID: 2682665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burkitt lymphoma--a stalking horse for cancer research?
    Klein G
    Semin Cancer Biol; 2009 Dec; 19(6):347-50. PubMed ID: 19607918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus and the pathogenesis of Burkitt's lymphoma: more questions than answers.
    Bornkamm GW
    Int J Cancer; 2009 Apr; 124(8):1745-55. PubMed ID: 19165855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2.
    Kelly G; Bell A; Rickinson A
    Nat Med; 2002 Oct; 8(10):1098-104. PubMed ID: 12219084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How does Epstein-Barr virus (EBV) complement the activation of Myc in the pathogenesis of Burkitt's lymphoma?
    Allday MJ
    Semin Cancer Biol; 2009 Dec; 19(6):366-76. PubMed ID: 19635566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Burkitt lymphoma: revisiting the pathogenesis of a virus-associated malignancy.
    Kelly GL; Rickinson AB
    Hematology Am Soc Hematol Educ Program; 2007; ():277-84. PubMed ID: 18024641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. l-Asparaginase synergizes with etoposide via the PI3K/Akt/mTOR pathway in Epstein-Barr virus-positive Burkitt lymphoma.
    Sang W; Tu D; Zhang M; Qin Y; Yin W; Song X; Sun C; Yan D; Wang X; Zeng L; Li Z; Xu K; Xu L
    J Biochem Mol Toxicol; 2022 Aug; 36(8):e23117. PubMed ID: 35757978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. To the genesis of Burkitt lymphoma: regulation of apoptosis by EBNA-1 and SAP may determine the fate of Ig-myc translocation carrying B lymphocytes.
    Nagy N; Klein G; Klein E
    Semin Cancer Biol; 2009 Dec; 19(6):407-10. PubMed ID: 19874894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus, the TCL-1 oncogene and Burkitt's lymphoma.
    Bell A; Rickinson AB
    Trends Microbiol; 2003 Nov; 11(11):495-7. PubMed ID: 14607063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burkitt and Burkitt-Like Lymphomas: a Systematic Review.
    Saleh K; Michot JM; Camara-Clayette V; Vassetsky Y; Ribrag V
    Curr Oncol Rep; 2020 Mar; 22(4):33. PubMed ID: 32144513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of SAHA and bortezomib up-regulates CDKN2A and CDKN1A and induces apoptosis of Epstein-Barr virus-positive Wp-restricted Burkitt lymphoma and lymphoblastoid cell lines.
    Hui KF; Leung YY; Yeung PL; Middeldorp JM; Chiang AK
    Br J Haematol; 2014 Dec; 167(5):639-50. PubMed ID: 25155625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on Burkitt Lymphoma.
    Dunleavy K; Little RF; Wilson WH
    Hematol Oncol Clin North Am; 2016 Dec; 30(6):1333-1343. PubMed ID: 27888884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.